» Articles » PMID: 38068773

Intermittent Fasting on Neurologic Diseases: Potential Role of Gut Microbiota

Overview
Journal Nutrients
Date 2023 Dec 9
PMID 38068773
Authors
Affiliations
Soon will be listed here.
Abstract

As the global population ages, the prevalence of neurodegenerative diseases is surging. These disorders have a multifaceted pathogenesis, entwined with genetic and environmental factors. Emerging research underscores the profound influence of diet on the development and progression of health conditions. Intermittent fasting (IF), a dietary pattern that is increasingly embraced and recommended, has demonstrated potential in improving neurophysiological functions and mitigating pathological injuries with few adverse effects. Although the precise mechanisms of IF's beneficial impact are not yet completely understood, gut microbiota and their metabolites are believed to be pivotal in mediating these effects. This review endeavors to thoroughly examine current studies on the shifts in gut microbiota and metabolite profiles prompted by IF, and their possible consequences for neural health. It also highlights the significance of dietary strategies as a clinical consideration for those with neurological conditions.

Citing Articles

Gut-brain axis mediated by intestinal content microbiota was associated with Zhishi Daozhi decoction on constipation.

Fang L, Yi X, Shen J, Deng N, Peng X Front Cell Infect Microbiol. 2025; 15:1539277.

PMID: 39963403 PMC: 11830728. DOI: 10.3389/fcimb.2025.1539277.


Intermittent Fasting Improves Sevoflurane-Induced Cognitive Dysfunction in Rats Through SIRT1-Mediated Autophagy.

Sun F, Tian Y Neurochem Res. 2025; 50(1):81.

PMID: 39831923 DOI: 10.1007/s11064-025-04335-9.


Intermittent fasting as a treatment for obesity in young people: a scoping review.

Bakhsh J, Salvy S, Vidmar A NPJ Metab Health Dis. 2025; 2(1):39.

PMID: 39744147 PMC: 11685102. DOI: 10.1038/s44324-024-00041-2.


Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?.

Zhang S, Lu J, Jin Z, Xu H, Zhang D, Chen J Front Pharmacol. 2024; 15:1459655.

PMID: 39355779 PMC: 11442227. DOI: 10.3389/fphar.2024.1459655.


Intermittent Fasting in Youth: A Scoping Review.

Bakhsh J, Vidmar A, Salvy S Res Sq. 2024; .

PMID: 39011109 PMC: 11247931. DOI: 10.21203/rs.3.rs-4524102/v1.


References
1.
Bai M, Wang Y, Han R, Xu L, Huang M, Zhao J . Intermittent caloric restriction with a modified fasting-mimicking diet ameliorates autoimmunity and promotes recovery in a mouse model of multiple sclerosis. J Nutr Biochem. 2020; 87:108493. DOI: 10.1016/j.jnutbio.2020.108493. View

2.
Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T . Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. Cell Res. 2019; 29(10):787-803. PMC: 6796854. DOI: 10.1038/s41422-019-0216-x. View

3.
Gregor A, Huber L, Auernigg-Haselmaier S, Sternberg F, Billerhart M, Dunkel A . A Comparison of the Impact of Restrictive Diets on the Gastrointestinal Tract of Mice. Nutrients. 2022; 14(15). PMC: 9370610. DOI: 10.3390/nu14153120. View

4.
Vogt N, Kerby R, Dill-McFarland K, Harding S, Merluzzi A, Johnson S . Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017; 7(1):13537. PMC: 5648830. DOI: 10.1038/s41598-017-13601-y. View

5.
Vieira S, Pagovich O, Kriegel M . Diet, microbiota and autoimmune diseases. Lupus. 2014; 23(6):518-26. PMC: 4009622. DOI: 10.1177/0961203313501401. View